Focus on gastroesophageal reflux disease in patients with cystic fibrosis
Annarita Bongiovanni1, Sara Manti2, Giuseppe Fabio Parisi1
1Department of Clinical and Experimental Medicine, Pediatric Respiratory Unit, San Marco Hospital, University of Catania, Catania 95123, Italy.
Insights
Gastroesophageal reflux disease (GERD) is common in cystic fibrosis (CF) patients, often starting in childhood. This review covers GERD
Area of Science:
- Gastroenterology and Pulmonology
- Pediatric Health
Background:
- Gastroesophageal reflux disease (GERD) is a frequent comorbidity in cystic fibrosis (CF).
- GERD prevalence in CF patients is notably high, often manifesting in childhood.
- Existing diagnostic and therapeutic guidelines for GERD are not specific to CF patients.
Purpose of the Study:
- To review the pathophysiology linking CF and GERD.
- To outline diagnostic and therapeutic strategies for GERD in CF.
- To discuss complications and future management directions for GERD in CF.
Main Methods:
- Literature review of studies on GERD in CF patients.
- Analysis of pathogenetic mechanisms connecting CF and GERD.
- Synthesis of current diagnostic and treatment approaches.
Main Results:
- Multiple pathogenetic mechanisms contribute to the CF-GERD association.
- Current GERD management in CF relies on non-CF-specific guidelines.
- There is a need for tailored approaches to GERD in CF.
Conclusions:
- Understanding the unique aspects of GERD in CF is crucial.
- Development of CF-specific GERD guidelines is warranted.
- Further research is needed to optimize GERD management in cystic fibrosis.
Abstract:
Gastroesophageal reflux disease (GERD) is a common gastrointestinal disorder in cystic fibrosis (CF), and based on various studies, its prevalence is elevated since childhood. There are several pathogenetic mechanisms on the basis of association between CF and GERD. However, there are no specific guidelines for GERD in CF patients, so diagnosis is based on guidelines performed on patients not affected by CF. The aim of this review is to provide the pathophysiology, diagnostic and therapeutic options, complications, and future directions in the management of GERD patients with CF.
More Related Videos
10:18Real-Time, Semi-Automated Fluorescent Measurement of the Airway Surface Liquid pH of Primary Human Airway Epithelial Cells
Published on: June 13, 2019
06:57The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
